Therefore, we have established that there is a notable reduction in TRIM26 levels in liver tissues, which exhibits a negative association with the expression of markers indicative of non-alcoholic steatohepatitis (NASH) in both human subjects and a mouse model of NASH. Here, TRIM26 is linked to metabolic dysfunction-associated steatohepatitis.